Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)

One means of stimulating the mammalian innate immune system is via Toll-like receptor 9 (TLR9) being exposed to unmethylated cytosine-phosphate-guanine (CpG) DNA, also known as pathogen-associated molecular patterns (PAMPs) of microbial origin. Synthetic CpG oligodeoxynucleotides (ODNs) with defined...

Full description

Bibliographic Details
Main Authors: Pramod N. Nehete, Lawrence E. Williams, Sriram Chitta, Bharti P. Nehete, Akash G. Patel, Margish D. Ramani, Thomas Wisniewski, Henrieta Scholtzova
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2020.00036/full
_version_ 1818196502309240832
author Pramod N. Nehete
Pramod N. Nehete
Lawrence E. Williams
Sriram Chitta
Bharti P. Nehete
Akash G. Patel
Margish D. Ramani
Thomas Wisniewski
Thomas Wisniewski
Thomas Wisniewski
Henrieta Scholtzova
Henrieta Scholtzova
author_facet Pramod N. Nehete
Pramod N. Nehete
Lawrence E. Williams
Sriram Chitta
Bharti P. Nehete
Akash G. Patel
Margish D. Ramani
Thomas Wisniewski
Thomas Wisniewski
Thomas Wisniewski
Henrieta Scholtzova
Henrieta Scholtzova
author_sort Pramod N. Nehete
collection DOAJ
description One means of stimulating the mammalian innate immune system is via Toll-like receptor 9 (TLR9) being exposed to unmethylated cytosine-phosphate-guanine (CpG) DNA, also known as pathogen-associated molecular patterns (PAMPs) of microbial origin. Synthetic CpG oligodeoxynucleotides (ODNs) with defined CpG motifs possess broad immunostimulatory properties that make CpG ODNs suitable as therapeutic interventions in a variety of human disease conditions, including Alzheimer’s disease (AD). Rodent models are often used to preclinically test the effectiveness of CpG ODN therapeutic agents for AD and other disorders. However, the translatability of findings in such models is limited due to the significant difference of the expression of TLR9 between primates and rodents. The squirrel monkey (SQM), a New World non-human primate (NHP), is known to be phylogenetically proximate to humans, and develops extensive age-dependent cerebral amyloid angiopathy (CAA), a key pathological feature of AD. Hence, this model is currently being used to test AD therapeutics. In the present study, we conducted the first examination of Class C CpG ODN’s immunomodulatory role in elderly SQMs. We documented the effectiveness of CpG ODN to trigger an immune response in an aged cohort whose immune system is senescent. The specific immune response patterns detected here closely resembled CpG ODN-induced immunostimulatory patterns observed in prior human studies. Overall, our findings provide critical data regarding the immunomodulatory potential of CpG ODN in this NHP model, allowing for future translational studies of innate immunity stimulation via TLR9 agonists for diverse indications, including AD therapeutics.
first_indexed 2024-12-12T01:35:06Z
format Article
id doaj.art-2321ed39357b49d380c5a7a5f31be649
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-12T01:35:06Z
publishDate 2020-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-2321ed39357b49d380c5a7a5f31be6492022-12-22T00:42:51ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652020-03-011210.3389/fnagi.2020.00036517020Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)Pramod N. Nehete0Pramod N. Nehete1Lawrence E. Williams2Sriram Chitta3Bharti P. Nehete4Akash G. Patel5Margish D. Ramani6Thomas Wisniewski7Thomas Wisniewski8Thomas Wisniewski9Henrieta Scholtzova10Henrieta Scholtzova11Department of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Bastrop, TX, United StatesThe University of Texas Graduate School of Biomedical Sciences, Houston, TX, United StatesDepartment of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Bastrop, TX, United StatesDepartment of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Bastrop, TX, United StatesDepartment of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Bastrop, TX, United StatesDepartment of Neurology, Center for Cognitive Neurology, New York University School of Medicine, New York, NY, United StatesDepartment of Pathology, New York University School of Medicine, New York, NY, United StatesDepartment of Neurology, Center for Cognitive Neurology, New York University School of Medicine, New York, NY, United StatesDepartment of Pathology, New York University School of Medicine, New York, NY, United StatesDepartment of Psychiatry, New York University School of Medicine, New York, NY, United StatesDepartment of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Bastrop, TX, United StatesDepartment of Neurology, Center for Cognitive Neurology, New York University School of Medicine, New York, NY, United StatesOne means of stimulating the mammalian innate immune system is via Toll-like receptor 9 (TLR9) being exposed to unmethylated cytosine-phosphate-guanine (CpG) DNA, also known as pathogen-associated molecular patterns (PAMPs) of microbial origin. Synthetic CpG oligodeoxynucleotides (ODNs) with defined CpG motifs possess broad immunostimulatory properties that make CpG ODNs suitable as therapeutic interventions in a variety of human disease conditions, including Alzheimer’s disease (AD). Rodent models are often used to preclinically test the effectiveness of CpG ODN therapeutic agents for AD and other disorders. However, the translatability of findings in such models is limited due to the significant difference of the expression of TLR9 between primates and rodents. The squirrel monkey (SQM), a New World non-human primate (NHP), is known to be phylogenetically proximate to humans, and develops extensive age-dependent cerebral amyloid angiopathy (CAA), a key pathological feature of AD. Hence, this model is currently being used to test AD therapeutics. In the present study, we conducted the first examination of Class C CpG ODN’s immunomodulatory role in elderly SQMs. We documented the effectiveness of CpG ODN to trigger an immune response in an aged cohort whose immune system is senescent. The specific immune response patterns detected here closely resembled CpG ODN-induced immunostimulatory patterns observed in prior human studies. Overall, our findings provide critical data regarding the immunomodulatory potential of CpG ODN in this NHP model, allowing for future translational studies of innate immunity stimulation via TLR9 agonists for diverse indications, including AD therapeutics.https://www.frontiersin.org/article/10.3389/fnagi.2020.00036/fullCpG ODN class Caged squirrel monkeycerebral amyloid angiopathycellular immune responseELISPOTcytokines
spellingShingle Pramod N. Nehete
Pramod N. Nehete
Lawrence E. Williams
Sriram Chitta
Bharti P. Nehete
Akash G. Patel
Margish D. Ramani
Thomas Wisniewski
Thomas Wisniewski
Thomas Wisniewski
Henrieta Scholtzova
Henrieta Scholtzova
Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
Frontiers in Aging Neuroscience
CpG ODN class C
aged squirrel monkey
cerebral amyloid angiopathy
cellular immune response
ELISPOT
cytokines
title Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
title_full Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
title_fullStr Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
title_full_unstemmed Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
title_short Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
title_sort class c cpg oligodeoxynucleotide immunomodulatory response in aged squirrel monkey saimiri boliviensis boliviensis
topic CpG ODN class C
aged squirrel monkey
cerebral amyloid angiopathy
cellular immune response
ELISPOT
cytokines
url https://www.frontiersin.org/article/10.3389/fnagi.2020.00036/full
work_keys_str_mv AT pramodnnehete classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT pramodnnehete classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT lawrenceewilliams classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT sriramchitta classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT bhartipnehete classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT akashgpatel classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT margishdramani classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT thomaswisniewski classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT thomaswisniewski classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT thomaswisniewski classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT henrietascholtzova classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis
AT henrietascholtzova classccpgoligodeoxynucleotideimmunomodulatoryresponseinagedsquirrelmonkeysaimiriboliviensisboliviensis